DTL
TXMD icon

Dynamic Technology Lab’s TherapeuticsMD TXMD Stock Holding History

Dynamic Technology Lab’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-280
Closed -$17K – 1492
2020
Q4 		$17K Sell
280
-308
-52% -$21K ﹤0.01% 935
2020
Q3 		$46K Buy
+588
New +$46.9K 0.01% 926
2017
Q4 		– Sell
-232
Closed -$62K – 1353
2017
Q3 		$62K Buy
+232
New +$67.1K 0.01% 988

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dynamic Technology Lab's TXMD Position: Q1 2021 in Review

Dynamic Technology Lab sold out of TherapeuticsMD (TXMD) in Q1 2021, closing a stake of 280 shares — an estimated $17K sold.

Dynamic Technology Lab first reported a position in TXMD in Q3 2017 and held it in 3 quarters. The position peaked at $62K in Q3 2017. 160 funds tracked by Wall St. Rank hold TXMD as of Q1 2021.

  • Dynamic Technology Lab reported no remaining TherapeuticsMD position as of Q1 2021 after selling out during the quarter.
  • Dynamic Technology Lab sold 280 TherapeuticsMD shares in Q1 2021, an estimated $17K.
  • Dynamic Technology Lab first reported a position in TherapeuticsMD in Q3 2017 and held it in 3 quarters.
  • Dynamic Technology Lab's TherapeuticsMD position peaked at $62K in Q3 2017.
  • 160 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2021.

Based on Dynamic Technology Lab's 13F filing for Q1 2021, filed 14 May 2021.